Clinical Trial IDNCT03812653
Lead SponsorUniversity of Michigan
Principal Investigator
Start Date2019-05-01
Completion Date2023-11-01
Study TypeInterventional
PhaseN/A
StatusNot yet recruiting

Purpose

The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.

Conditions

ConditionInterventionPhase
Ischemic Stroke, Sleep Apnea, Sleep Apnea, Obstructive, TIA, Stroke, CPAP, Telemedicine, Home Sleep Apnea Test, Randomized Clinical Trial, Multicenter TrialDevice: CPAPN/A

Eligibility

AgeGenderAccepts Healthy Volunteers
18 Years and older.AllNo